Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CasanovoGUI: a cross-platform desktop application for deep learning-based de novo peptide sequencing with Casanovo

Created on 18 Jul 2026

Authors

Wen, B., Li, K., Riffle, M., MacCoss, M. J., Bittremieux, W., Noble, W. S.

Abstract

De novo peptide sequencing detects peptides directly from tandem mass spectra without a protein sequence database, and deep learning has substantially advanced its performance. Casanovo, one such widely used model, is distributed as a Python command-line program. Consequently, installation, GPU and dependency configuration, and manual parameterization can be challenging for many bench scientists and are a recurring source of errors. Interpreting and validating the resulting predictions poses a further challenge. We present CasanovoGUI, an open-source Java-based desktop application that makes all of Casanovo's main analysis functions available through a point-and-click interface on Windows, macOS, and Linux. On first use, CasanovoGUI automatically installs a private Python environment and Casanovo with a GPU-matched build, requiring no prior software setup. The GUI provides access to Casanovo's analysis functions and configuration parameters, streams live progress, and integrates results interpretation: annotated spectra with per-residue confidence scores in the PDV viewer, and mismatch-tolerant mapping of de novo peptides back to a reference proteome. CasanovoGUI is available at https://github.com/Noble-Lab/CasanovoGUI.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 18 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 21
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement